Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy
Clinical trial NCT06982040 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06982040
- Sponsor
- Nanjing Chia-tai Tianqing Pharmaceutical
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-09-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.